Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinovirus Challenge in Asthmatics
NCT02910401Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Sep 2016
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 2, open-label trial (3 arms), sponsored by University of Virginia. Primary endpoints: Expression of Interleukin-25 Transcripts by Nasal Epithelial Cells at Day 4, Change in Lower Respiratory Symptom Scores and 1 more. Started Sep 2016; status: completed.
Beyond the preview
Go deeper on NCT02910401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02910401.